Kirby McInerney LLP is investigating potential claims against the Board of Directors of Receptos, Inc. (“Receptos” or the “Company”) (NASDAQ:RCPT) concerning the proposed acquisition of the Company by Celgene Corporation. Pursuant to the terms of the definitive agreement, Receptos stockholders will receive $232.00 in cash for each share of Receptos common stock they own, in a transaction valued at approximately $7.2 billion.

The investigation concerns whether the Receptos Board of Directors violated its fiduciary duties by agreeing to the proposed transaction and whether the proposed consideration adequately values the Company’s common stock.

If you are a Receptos stockholder and wish to obtain additional information, please contact J. Brandon Walker, Esq. by email at bwalker@kmllp.com, or telephone at (212) 699-1145 or toll free at (888) 529-4787, or by filling out this contact form. There is no cost or obligation to you.

Kirby McInerney LLP is a New York-based law firm concentrating in securities, whistleblower, antitrust and consumer litigation. For additional information, please go to www.kmllp.com.

Kirby McInerney LLPJ. Brandon Walker, Esq., (212) 699-1145toll free: (888) 529-4787bwalker@kmllp.com

RECEPTOS, INC. (NASDAQ:RCPT)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024 Click aqui para mais gráficos RECEPTOS, INC..
RECEPTOS, INC. (NASDAQ:RCPT)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024 Click aqui para mais gráficos RECEPTOS, INC..